BenefitsLink logo
EmployeeBenefitsJobs logo
Subscribe Now

“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Featured Jobs
ERISA Attorney (NY)
Retirement Recordkeeping Specialist (IN)
Defined Contribution Pension Administrator (FL)
401(k) Administrator (CA, Telecommute)
Retirement Plan Administration Specialist (AL)
ERISA Attorney (MI)
DB / DC Administrator (CA, Telecommute)
Retirement Plan Sales Consultant (CA)
Retirement Plan Consultant (Telecommute)
Pension Administrator - Retirement Plans (NJ, PA)
Get the BenefitsLink app LinkedIn

News Items, by Subject

Health plan costs - prescription drugs

Now Viewing
View Excerpts and

For the Asking, a Check Is in the Mail to Help Pay for Costly Drugs
[Opinion] Prescription Drugs and Price Controls: What the Debate Gets Wrong
[Official Guidance] Text of Department of Defense Interim Final Rule: TRICARE Pharmacy Benefits Program Reforms
Telemedicine Could See Uptick in 2019 with Change in Rules for Online Prescribing
Double Jeopardy in Health: It's Time for Employers to Care
CMS Office of the Actuary Releases 2017 National Health Expenditures
Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses: Highlights from the Proposed Rule
Drug Companies Draw Fire for Not Using Tax Savings to Lower Drug Prices
[Guidance Overview] CMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 2020
CVS Offers 'Guaranteed Net Cost' for Pharmacy Benefit Clients
[Guidance Overview] CMS Issues Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses
[Guidance Overview] Administration Proposes Strategies to Lower Pharmaceutical Prices in Medicare Part D
Medicare Plans Could Gain Drug Pricing Leverage Under CMS Proposal
Cost-Sharing and Drug-Price Transparency in New York
CMS Takes Action to Lower Prescription Drug Costs by Modernizing Medicare
[Guidance Overview] Text of CMS Fact Sheet: Contract Year 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule
[Official Guidance] Text of CMS Proposed Regs: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses
NY Approval Clears the Way for $69 Billion CVS Acquisition of Aetna
Employer Health Benefit Costs Predicted to Be Lower in 2019
In the Absence of Drug Rebates, New Alternatives Are Likely to Emerge
Branded Prescription Drug Prices Continue to Rise
Prescription Drug Importation: New Federal Initiatives and the Case for State Action
The New California Regulatory Scheme for Pharmacy Benefit Managers
Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle
Something Happened to U.S. Drug Costs in the 1990s
Big Change Ahead for Medicare -- and Employers Will Feel It, Too
Recent Trump Administration Proposals Aimed at Lowering Drug Costs
Managing Pharmacy Costs Through Focused Analytics (PDF)
[Guidance Overview] Drug Pricing Plan Would Tie Medicare Part B Reimbursement to International Prices
Trump Adds a Global Pricing Plan to Wide Attack on Drug Prices, But Doubts Persist
Trump Administration Outlines Plan to Lower Pharmaceutical Prices in Medicare Part B
[Guidance Overview] CMS Proposes International Pricing Index Model for Medicare Part B Drugs
[Official Guidance] Text of CMS Notice of Proposed Rulemaking: International Pricing Index Model for Medicare Part B Drugs
Following Federal Approval of CVS's Proposed Acquisition of Aetna, Attention Turns to New York State
CMS Proposes Rule to Require Drug Pricing Transparency
Requiring a Price Tag in Drug Commercials: Furthering Consumer Transparency or Government Overreach?
New Federal Laws Ban Gag Clauses in Pharmacy Contracts
[Guidance Overview] New California Law Aims to Increase PBM Disclosure and Transparency
Drugmakers Funnel Millions to Lawmakers
The Future of Drug Rebates: Are They to Be or Not to Be?
Express Scripts Covers Amgen, Lilly Migraine Therapies, Excludes Teva Drug
HHS Announces Drug Price Transparency Proposal, Foreshadows Additional Regulatory Action to Address Drug Prices
Trump Administration Outlines Plan to Put Drug Prices in TV Ads
TV Ads Must Trumpet Drug Prices, Trump Administration Says; Pharma Tries a Plan B
[Guidance Overview] HHS Fact Sheet: What You Need to Know about Putting Drug Prices in TV Ads
[Guidance Overview] CMS Proposes Requirement that Manufacturers Disclose Drug Prices in Television Ads
[Official Guidance] Text of CMS Proposed Regs: Medicare and Medicaid Programs -- Drug Pricing Transparency
Strategies for Controlling Prescription Drug Costs
[Opinion] On Drug Prices, Pharmacy Benefit Managers Are Not The Problem
No More Secrets: Congress Bans Pharmacist 'Gag Orders' on Drug Prices
California Law Will Put Limits on PBMs, Add Notice Requirements
Recent Trends and Characteristics of Employees with High Prescription Drug Spending
Aetna to Sell Medicare Part D Drug Business to WellCare Health
[Opinion] Pharmacy Spread Pricing Exposed
Specialty Drugs, Biosimilars and Your Health Benefit Plan
Senate Votes 98-2 to Ban Pharmacist Gag Clauses
Justice Department Approves Cigna-Express Scripts Merger
High Drug Prices and Promising Policy Proposals: What the Evidence Says
Leading PBMs Unveil Excluded Drugs
Determining Whether Prescription Drug Coverage Is Creditable (PDF)
About Us


Privacy Policy

Post a Job

Advertise in the BenefitsLink Newsletters

Add Your Company to the Directory of Vendors and Software

Submit a News Item, Press Release, Webcast or Conference

Contact Us

Payment Portal

© 2018, Inc.